Entries by medicalps

A medtech startup ready for a pitch ?

MassMEDIC will host its 18th Annual MedTech Showcase on Friday, October 27 at the Westin Hotel in Waltham. This is the region’s premier event for entrepreneurs, potential investors and partners to gather and learn more about the technologies and business plans of over 20 select emerging medtech companies. The event’s focus is the 10-minute pitches made […]

Advicenne to Present Preliminary Phase III Clinical Data on ADV7103

Nimes, France, June 21, 2017 – Advicenne, a late-stage biopharmaceutical company focused on the development of paediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announces today that the Company will present preliminary Phase III clinical data on ADV7103 in an oral presentation at the upcoming 50th European Society of Paediatric Nephrology (ESPN) […]

Eurofins-Optimed Brings Clinical Trials Stateside, Opens Cambridge Office

Eurofins-Optimed, a worldwide leader in early clinical trials, announced the opening of its Boston-area office, located in the Cambridge Innovation Center (CIC) in Cambridge, Massachusetts. Eurofins-Optimed is the Clinical Competence Center of Eurofins Group, a global leader in BioPharmaceutical product testing. The company now expects to leverage the tremendous resources of its global network in […]

ARAYMONDLIFE welcomes the French commercial delegation of CEVA Animal Health

On Wednesday, April 05th, 2017, ARaymondlife welcomed the French sales team of CEVA, French veterinary laboratory world’s top ranked. The goal of this visit for the 20 sales staff accompanied by their Branch Manager, Product Manager and Key Account Manager was to discover the infrastructure and the complex manufacturing process of the flagship product of […]

LETI announces EU “New Deal”project to create nanotherapy that specifically targets inflammatory bowel diseases

Leti, a technology research institute of CEA Tech, announced a European Union project to develop a nanotherapy targeting the molecules involved in inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis. An estimated 3 million people in Europe, mostly adolescents and young adults, have been diagnosed with inflammatory bowel diseases, which are chronic […]

Horizon 2020 project: PERMIDES

Advancing precision medicine in the digital age requires solutions developed in the IT and software sector, e.g. big data, machine learning, IT security, data protection, and cross-enterprise collaboration. The PERMIDES project aims at bringing together SMEs (micro, small and medium-sized enterprises) from the biopharmaceutical and IT sector to advance precision medicine through the development of […]

,

PSI signs an exclusive supply agreement of ALPAO’s deformable mirrors for retinal imagers

Physical Sciences Inc. (PSI), provider of new retinal imager for non-invasive medical diagnostics, will purchase deformable mirror (DM) exclusively from ALPAO, designer and manufacturer of adaptive optics products. Adaptive Optics (AO), increasingly used for retina imaging, enables doctors and researchers to observe and analyze the smallest details of the retina, such as rods and cones. […]

,

SYNAPCELL is recruiting an In vivo NeuroScientist

SYNAPCELL is an innovative company providing pharmaceutical and biotech industries with drug discovery solutions for CNS pathologies, based on EEG biomarkers and predictive animal models. To support its development, SYNAPCELL is looking for an in vivo Neuroscientist. For more information, click here.

SYNTHELIS launches a new High Throughput Multigene Expression service!

SYNTHELIS, a French biotech company, specialized in cell-free production, purification and characterization of difficult-to-express proteins (ion channels, transporters, GPCRs, enzymes, etc.) announced today the launch of a new High Throughput Multigene Expression services. “Working in close relationship with our customers, we are well aware of current challenges in protein production. As a result, SYNTHELIS is […]